Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Resistance, Multiple”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02829827
What this trial is testing

Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS)

Who this might be right for
Infantile Spasms (IS)
UCB Biopharma S.P.R.L. 3
Not applicableLooking for participantsNCT05117788
What this trial is testing

Bioneer Q-RFIA Clinical Evaluation

Who this might be right for
Tuberculosis, Multidrug-Resistant
Foundation for Innovative New Diagnostics, Switzerland 2,350
Large-scale testing (Phase 3)Study completedNCT02707861
What this trial is testing

Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1

Who this might be right for
HIV
TaiMed Biologics Inc. 79
Large-scale testing (Phase 3)Ended earlyNCT01455246
What this trial is testing

Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis

Who this might be right for
CirrhosisAscitesNosocomial Spontaneous Bacterial Peritonitis
University of Padova 32
Large-scale testing (Phase 3)Study completedNCT00344422
What this trial is testing

Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaMyelomaM-Protein+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 198
Testing effectiveness (Phase 2)Looking for participantsNCT06321536
What this trial is testing

Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)

Who this might be right for
Multi-Drug Resistant Organism Colonization
Emory University 60
Not applicableStudy completedNCT04043793
What this trial is testing

ICU-acquired Colonization and Infection Related to MDR in Immunocompromised Patients

Who this might be right for
Immunocompromised HostCritical Care
University Hospital, Lille 759
Testing effectiveness (Phase 2)Active Not RecruitingNCT02452008
What this trial is testing

Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Very early researchStudy completedNCT00572598
What this trial is testing

Pilot Study of 18F Fluoropaclitaxel (FPAC)

Who this might be right for
Breast Cancer
Virginia Commonwealth University 6
Early research (Phase 1)WithdrawnNCT06842589
What this trial is testing

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS

Who this might be right for
Multi-Drug Resistant Nephrotic SyndromeCAR-T Cell Therapy
The Children's Hospital of Zhejiang University School of Medicine
Not applicableUnknownNCT05932355
What this trial is testing

Synergistic Effect of Plasmid Inhibitors and Antimicrobial Drugs Against Clinical MDR-hvKP

Who this might be right for
Synergy Between Plasmid Inhibitors and Combined Antibiotics
Assiut University 50
Large-scale testing (Phase 3)Study completedNCT00144170
What this trial is testing

Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)

Who this might be right for
HIV Infections
Boehringer Ingelheim 882
Not applicableStudy completedNCT04574596
What this trial is testing

Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli

Who this might be right for
E Coli Infection
Duke University 300
Large-scale testing (Phase 3)Study completedNCT00002220
What this trial is testing

Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 120
Not applicableEnded earlyNCT04783727
What this trial is testing

PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantBacterial Infections+1 more
Research Center Borstel 4
Early research (Phase 1)Study completedNCT03910673
What this trial is testing

Intravenous Fosfomycin Pharmacokinetics Study

Who this might be right for
Bacterial InfectionMultiple-drug ResistancePathogen Resistance
National Institute of Allergy and Infectious Diseases (NIAID) 39
Not applicableStudy completedNCT02653157
What this trial is testing

Multidrug Resistant Gram-negative Bacilli Colonization and Infection in Burn

Who this might be right for
Multi-drug Resistant Gram-negative Bacilli Colonization
University of North Carolina, Chapel Hill 48
Not applicableStudy completedNCT06148480
What this trial is testing

Perinatal Transmission of MDR Bacteria

Who this might be right for
E. Coli InfectionMulti-antibiotic Resistance
Ann & Robert H Lurie Children's Hospital of Chicago 200
Not applicableNot Yet RecruitingNCT07647796
What this trial is testing

Infection Prevention for "Bellwether" Surgery in Ethiopia

Who this might be right for
Ceserean SectionLower Limb FracturesSurgical Site Infection (SSI)
Karolinska Institutet 1,000
Testing effectiveness (Phase 2)Study completedNCT02573350
What this trial is testing

A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683

Who this might be right for
Tuberculosis, Multidrug-Resistant
Otsuka Pharmaceutical Development & Commercialization, Inc. 213
Next Page